According to an announcement issued by the US Food and Drug Administration (FDA) on May 1st, the FDA has recently sent warning letters to 14 online retailers for selling e-cigarette products without authorization from the FDA. The products are also popular among teenagers. The warning letters involve well-known e-cigarette brands such as Elf Bar/EB Design, Esco Bars, Funky Republic, Hyde, Kang, Cali Bars, and Lost Mary.
According to the 2023 National Youth Tobacco Consumption Survey, out of over 2.1 million adolescents reported currently using e-cigarette products, more than 50% are using Elf Bar products, while over 20% are using Esco Bar products.
Retailers who receive these warning letters, for selling or distributing e-cigarette products in the United States without FDA authorization, are in violation of the Federal Food, Drug, and Cosmetic Act. Recipients of the warning letters must respond within 15 business days and detail the actions they will take to address the violations mentioned in the warning letter and prevent future occurrences. Failure to promptly address these violations may prompt the FDA to take further action, such as injunctions, seizures, and/or civil penalties.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
